Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Nature Medicine
|
December 15, 2010
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang, Zong-Yi Li, Ying Liu, et al.
Gynecologic Oncology
|
December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R Conner, Emily Meserve, Ellen Pizer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2022
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
Ehsan Irajizad, Chae Y Han, Joseph Celestino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Saul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
Tanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Nature Medicine
|
December 15, 2010
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang, Zong-Yi Li, Ying Liu, et al.
Gynecologic Oncology
|
December 17, 2013
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations
James R Conner, Emily Meserve, Ellen Pizer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2022
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
Ehsan Irajizad, Chae Y Han, Joseph Celestino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Saul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
Tanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Page
of 3